GRDN — Guardian Pharmacy Services Cashflow Statement
0.000.00%
- $2.77bn
- $2.73bn
- $1.45bn
Annual cashflow statement for Guardian Pharmacy Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.3 | 49.7 | 37.7 | -71 | 49 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 15.1 | 1.02 | -0.737 | 139 | 19.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.47 | -18.7 | 15.6 | -29.4 | 6.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 58.5 | 48.5 | 70.8 | 58 | 100 |
| Capital Expenditures | -9.28 | -16.8 | -14.6 | -16.4 | -19.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3.87 | -1.13 | 1.11 | -14 | -12.7 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.1 | -17.9 | -13.4 | -30.4 | -32.2 |
| Financing Cash Flow Items | -30.7 | -42.2 | -54.3 | 12.8 | 26.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -36.8 | -45 | -57.2 | -23.6 | -7.07 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.56 | -14.4 | 0.145 | 3.91 | 61 |